Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
UCI-Fred Hutch collaboration turns 10
In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Physician assistant Debra Mattson to retire May 24
She has been the historian — and the heart —of the Infectious Disease Consult Service
Dr. Sue Biggins elected to American Academy of Arts & Sciences
Biologist is ninth Hutch researcher to join one of the nation's oldest learned societies
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
When scientific hypotheses don’t pan out
Research studies are often built around an educated guess. What happens when those guesses are wrong?
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Stealing a secret from an unwelcome virus
An unexpected discovery in a herpes lab might bring relief to cancer patients
Training tomorrow's HIV researchers
With no end yet to the pandemic, a program supports young South African physician-scientists
Cytomegalovirus causes transient prior to lifelong infection
Schiffer Laboratory, Vaccine and Infectious Disease Division
Good News at Fred Hutch
Celebrating faculty and staff achievements
Good News: Bricker resolution tips, vote for Open Science Prize, 425 Magazine salute to HIV research
Celebrating faculty and staff achievements
Good News: Dr. Oliver Press wins mentorship award; Seattle magazine names Dr. Larry Corey to Seattle's 'Hall of Fame'
Celebrating faculty and staff achievements
Can immunotherapy cure HIV?
A revolution in cancer care may offer clues to a cure or remission for HIV/AIDS
AIDS 2016: Beyond HIV treatment to vaccines and a cure, calls to finish the job
Beyond HIV treatment to vaccines and a cure, calls to finish the job — and leave no one behind
HIV vaccine clinical trials take center stage at world's largest global health conference
'The HIV vaccine field is open for business,' said Fred Hutch's Dr. Larry Corey at International AIDS Society's biennial meeting in Durban, South Africa
Renewed hope at AIDS conference for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
International AIDS Conference: Where we’ve been, what’s next in the quest to end HIV
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next